IBS DAYS 2024
Bologna, ltaly, 17 - 19 Jun 2024
We will be attending IBS Days 2024 in Italy. This event will acts as a platform to explore worldwide perspectives on irritable bowel syndrome (IBS). It will encompass a wide range of topics including epidemiology, genetic influences, the role of diet, microbiota, immune pathways, infectious triggers, diagnostic modalities, biomarker advancements, and therapeutic interventions.
Billy Boyle is an engineering graduate from the University of Cambridge. He is one of the original co-founders of Owlstone Inc, spun out of Cambridge in 2004 with the goal of developing the applications of field asymmetric ion mobility spectroscopy (FAIMS).
Billy started to focus on the medical applications of FAIMS technology after his wife, Kate, was diagnosed and later died of colon cancer as a result of a late diagnosis. He worked closely with clinical partners who integrated FAIMS technology across a broad spectrum of research studies.
Positive results helped to spin-out, and secure initial funding for, Owlstone Medical. With ongoing clinical and commercial success, Billy led this process and became the founding CEO upon the close of a $7M investment in March 2016. The mission of Owlstone Medical is to save 100,000 lives and $1.5B in healthcare costs.